Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
The regulatory function is vital in making safe and effective healthcare products available worldwide. Individuals who ensure regulatory compliance and prepare submissions, as well as those whose main job function is clinical affairs or quality assurance are all considered regulatory professionals.
One of our most valuable contributions to the profession is the Regulatory Code of Ethics. The Code of Ethics provides regulatory professionals with core values that hold them to the highest standards of professional conduct.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Like all professions, regulatory is based on a shared set of competencies. The Regulatory Competency Framework describes the essential elements of what is required of regulatory professionals at four major career and professional levels.
Join the brightest minds in regulatory at the annual Regulatory Convergence. See the global regulatory community in action. Intensive workshops. Topical sessions. Meet ups with regulators. This is where it all comes together.
For 20 years, our flagship publication, Fundamentals of US Regulatory Affairs, has been giving regulatory professionals the insights and answers they need, right at their fingertips.
There are hundreds of RAC testing centers available worldwide. Any of the four RAC exams (US, EU, CAN or Global) may be taken at any location. Find an upcoming exam at a location near you.
The site navigation utilizes arrow, enter, escape, and space bar key commands. Left and right arrows move across top level links and expand / close menus in sub levels. Up and Down arrows will open main level menus and toggle through sub tier links. Enter and space open menus and escape closes them as well. Tab will move on to the next part of the site rather than go through menu items.
Posted 30 July 2012 | By Alexander Gaffney, RAC
The US Food and Drug Administration (FDA) released new guidance on 25 July for industry regarding three quality documents released by the International Conference on Harmonization (ICH) related to how manufacturers and sponsors can best prepare these documents for inspection by regulators in the US, EU and Japan.
The guidance is co-sponsored by FDA's Centers for Drug Evaluation and Research (CDER) and Biologics Evaluation and Research (CBER), both of which are in charge of assessing and implementing ICH's Q8 (Pharmaceutical Development), Q9 (Quality Risk Management) and Q10 (Pharmaceutical Quality System) quality documents. According to ICH, the three documents have been the subject of some confusion, and the harmonizing organization released additional implementation guidance in the form of a question-and-answer document to quell concerns.
FDA's guidance adopts ICH's language from its "Points to Consider" document for the three quality guidelines, which FDA noted is based on several training workshops conducted by ICH between 2009 and 2011.
US regulators also cautioned that the document is not intended to be new guidance in the traditional sense of the word, but rather exists to, "provide clarity to both industry and regulators and to facilitate the preparation, assessment and inspection related to applications filed for marketing authorizations."
The guidance goes on to describe a number of aspects for regulatory professionals to consider, including the relationship between risk and potential harm, conducting risk assessments, linking potential harms to harm-reduction strategies, controlling a product's risk throughout its lifecycle, continuous improvement strategies, scalability of control strategies, real-time release testing and batch release decisions.
Additional guidance is available on the role of models in quality by design, points to consider for design space and processes for validation and continuous process verification.
Read more:
FDA - Q8, Q9, & Q10 Questions and Answers -- Appendix: Q&As from Training Sessions (Q8, Q9, & Q10 Points to Consider)
Tags: Q10, Q9, Q8, Points to Consider, Harmonisation, Q&A, harmonization, Latest News
Regulatory Focus newsletters
All the biggest regulatory news and happenings.